Federation des caisses Desjardins du Quebec boosted its position in Equifax, Inc. (NYSE:EFX - Free Report) by 42.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 45,164 shares of the credit services provider's stock after buying an additional 13,374 shares during the quarter. Federation des caisses Desjardins du Quebec's holdings in Equifax were worth $11,003,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in Equifax by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 14,708,331 shares of the credit services provider's stock valued at $3,582,361,000 after purchasing an additional 318,826 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in Equifax by 40.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 7,037,804 shares of the credit services provider's stock valued at $1,714,129,000 after purchasing an additional 2,009,987 shares during the period. Harris Associates L P boosted its holdings in Equifax by 27.6% in the 1st quarter. Harris Associates L P now owns 4,570,557 shares of the credit services provider's stock valued at $1,113,205,000 after purchasing an additional 987,772 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Equifax by 119.3% during the 1st quarter. JPMorgan Chase & Co. now owns 1,453,618 shares of the credit services provider's stock worth $354,044,000 after acquiring an additional 790,919 shares during the period. Finally, Northern Trust Corp lifted its holdings in shares of Equifax by 2.8% during the 1st quarter. Northern Trust Corp now owns 1,240,783 shares of the credit services provider's stock worth $302,205,000 after acquiring an additional 33,558 shares during the period. 96.20% of the stock is currently owned by institutional investors and hedge funds.
Equifax Price Performance
EFX stock traded up $9.21 during trading on Friday, hitting $249.81. 1,381,888 shares of the stock traded hands, compared to its average volume of 925,086. Equifax, Inc. has a one year low of $199.98 and a one year high of $309.63. The stock has a market cap of $30.93 billion, a price-to-earnings ratio of 48.89, a P/E/G ratio of 3.00 and a beta of 1.68. The company has a 50 day simple moving average of $250.03 and a 200 day simple moving average of $249.87. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.79.
Equifax (NYSE:EFX - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The credit services provider reported $2.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.92 by $0.08. Equifax had a net margin of 10.95% and a return on equity of 18.89%. The firm had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.51 billion. During the same period last year, the firm posted $1.82 EPS. The firm's quarterly revenue was up 7.4% on a year-over-year basis. Equifax has set its Q3 2025 guidance at 1.870-1.970 EPS. FY 2025 guidance at 7.330-7.630 EPS. Equities analysts expect that Equifax, Inc. will post 7.58 EPS for the current fiscal year.
Equifax Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Tuesday, September 2nd will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, September 2nd. Equifax's dividend payout ratio (DPR) is presently 39.14%.
Analyst Upgrades and Downgrades
EFX has been the subject of a number of analyst reports. Needham & Company LLC reaffirmed a "buy" rating and set a $295.00 price objective on shares of Equifax in a report on Friday, June 20th. Morgan Stanley reaffirmed an "overweight" rating and set a $305.00 price objective (up from $295.00) on shares of Equifax in a report on Tuesday, June 10th. Wells Fargo & Company reduced their price objective on shares of Equifax from $310.00 to $300.00 and set an "overweight" rating for the company in a report on Wednesday, July 23rd. Bank of America downgraded shares of Equifax from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $300.00 to $285.00 in a report on Monday, June 23rd. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and set a $300.00 price objective on shares of Equifax in a report on Wednesday, June 18th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, Equifax presently has a consensus rating of "Moderate Buy" and a consensus target price of $283.53.
Check Out Our Latest Stock Report on Equifax
Insiders Place Their Bets
In other Equifax news, CEO Mark W. Begor sold 48,264 shares of the firm's stock in a transaction dated Monday, July 28th. The shares were sold at an average price of $241.71, for a total value of $11,665,891.44. Following the completion of the sale, the chief executive officer owned 142,872 shares in the company, valued at approximately $34,533,591.12. This trade represents a 25.25% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 1.40% of the company's stock.
Equifax Company Profile
(
Free Report)
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Featured Articles

Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report